NeuroPace, Inc. (NPCE) has a negative trailing P/E of -22.2, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 39.4 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -4.50%, forward earnings yield 2.54%.
Criteria proven by this page:
Overall SharesGrow Score: 55/100 with 3/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2019 | -9.2 | 0.00 | -2.14 | 7.50 | - |
| 2020 | -11.4 | 0.58 | -1.87 | 6.74 | - |
| 2021 | -4.6 | 0.00 | 2.28 | 3.71 | - |
| 2022 | -0.8 | 0.06 | 1.05 | 0.81 | - |
| 2023 | -8.1 | 0.24 | 12.90 | 4.07 | - |
| 2024 | -12.0 | 0.45 | 40.67 | 4.08 | - |
| 2025 | -23.5 | 0.81 | 26.55 | 5.05 | - |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2019 | $-1.71 | $36.97M | $-40.74M | -110.2% |
| 2020 | $-1.51 | $41.14M | $-35.98M | -87.5% |
| 2021 | $-1.56 | $45.18M | $-38.11M | -84.3% |
| 2022 | $-2.17 | $45.52M | $-53.37M | -117.2% |
| 2023 | $-1.27 | $65.42M | $-32.96M | -50.4% |
| 2024 | $-0.93 | $79.91M | $-27.14M | -34% |
| 2025 | $-0.66 | $99.99M | $-21.47M | -21.5% |
| Year | EPS (Avg) | EPS Range | Revenue (Avg) | Revenue Range | Analysts |
|---|---|---|---|---|---|
| 2026 | $-0.62 | $-0.87 – $-0.46 | $98.91M | $98.48M – $99.14M | 6 |
| 2027 | $-0.35 | $-0.43 – $-0.24 | $123.1M | $122.27M – $123.94M | 5 |
| 2028 | $-0.09 | $-0.55 – $0.22 | $153.59M | $153.58M – $153.6M | 5 |
| 2029 | $0.39 | $0.38 – $0.40 | $184.83M | $180.82M – $187.51M | 1 |
| 2030 | $0.36 | $0.35 – $0.37 | $213.41M | $208.78M – $216.51M | 1 |
